|
Acoustic Neuroma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Immunohistochemical expression of M-CSF and IL-34 was analyzed in ten fast-growing vestibular schwannomas and in ten slow-growing vestibular schwannomas.
|
30580386 |
2019 |
|
Acute lymphocytic leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
By contrast, detectable CSF-1 receptors were uniformly absent on blasts from 19 children with acute lymphoblastic leukemia.
|
2465043 |
1989 |
|
Acute myelomonocytic leukemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
M-CSF and M-CSF-receptor gene expression in acute myelomonocytic leukemias.
|
2154646 |
1990 |
|
Acute periodontitis
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Among these, three polymorphisms located in the colony stimulating factor 1 (CSF1) gene showed a positive association with AgP.
|
16844084 |
2006 |
|
Acute periodontitis
|
0.020 |
Biomarker
|
disease |
BEFREE |
Thus, this study aims to evaluate levels of the innate immunity-related markers calprotectin, colony-stimulating factor (CSF)-1, macrophage migration inhibitory factor (MIF), monokine induced by interferon-γ (MIG), and matrix metalloproteinase (MMP)-8 in serum and saliva from patients with generalized AgP and those with gingivitis or a healthy periodontium.
|
28753101 |
2017 |
|
Adenocarcinoma
|
0.040 |
AlteredExpression
|
group |
BEFREE |
Recent studies have demonstrated overexpression of CSF-1 and its receptor in breast, ovarian, and endometrial adenocarcinomas.
|
9815987 |
1995 |
|
Adenocarcinoma
|
0.040 |
Biomarker
|
group |
BEFREE |
Co-expression of M-CSF transcripts and protein, FMS (M-CSF receptor) transcripts and protein, and steroid receptor content in adenocarcinomas of the ovary.
|
7965406 |
1994 |
|
Adenocarcinoma
|
0.040 |
AlteredExpression
|
group |
BEFREE |
Because about half (6/14) of the invasive adenocarcinoma specimens were shown to coexpress fms and colony-stimulating factor 1, the authors propose that the expression of this lymphohematopoietic cytokine and its receptor by ovarian adenocarcinomas could contribute to their proliferative and invasive characteristics in vivo.
|
1695482 |
1990 |
|
Adenocarcinoma
|
0.040 |
AlteredExpression
|
group |
BEFREE |
A high expression of CSF1 correlated with shorter metastasis-free survival in the entire NSCLC group (P = .016) and in SCC (P = .049) and AC (P = .034) cohorts.
|
23870818 |
2013 |
|
Adult Hodgkin Lymphoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
During characterization of a cDNA library from the Hodgkin lymphoma (HL) cell line L-1236, we discovered a new transcript derived from chromosome 1 at the long intergenic non-protein coding RNA 1768 (LINC01768)/colony stimulating factor 1 (CSF1) region.
|
31731509 |
2019 |
|
Adult Leiomyosarcoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
CSF1 expression in nongynecological leiomyosarcoma is associated with increased tumor angiogenesis.
|
21854753 |
2011 |
|
Adult Lymphoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
A novel CSF-1 binding factor in a patient in complete remission following cytotoxic therapy for lymphoma.
|
7833270 |
1995 |
|
Adult Solid Neoplasm
|
0.010 |
Biomarker
|
group |
BEFREE |
The suppression of CSF-1 by RNA interference is therefore a powerful tool to block gene function and influence tumor-stroma interactions in solid tumor development.
|
17172715 |
2007 |
|
Aggressive Periodontitis
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Among these, three polymorphisms located in the colony stimulating factor 1 (CSF1) gene showed a positive association with AgP.
|
16844084 |
2006 |
|
Aggressive Periodontitis
|
0.020 |
Biomarker
|
disease |
BEFREE |
Thus, this study aims to evaluate levels of the innate immunity-related markers calprotectin, colony-stimulating factor (CSF)-1, macrophage migration inhibitory factor (MIF), monokine induced by interferon-γ (MIG), and matrix metalloproteinase (MMP)-8 in serum and saliva from patients with generalized AgP and those with gingivitis or a healthy periodontium.
|
28753101 |
2017 |
|
Albuminuria
|
0.200 |
Therapeutic
|
phenotype |
RGD |
The effect of macrophage colony-stimulating factor (M-CSF) on the progression of lipid-induced nephrotoxicity in diabetic nephropathy.
|
8573750 |
1996 |
|
ALZHEIMER DISEASE 10
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
MDR human ovarian cancer (AD10) cells were transduced with the human M-CSF gene inserted into an expression vector to establish gene-modified cells capable of producing low (ML-AD10), intermediate (MM-AD10) nd high (MH-AD10) amounts of M-CSF.
|
8698627 |
1996 |
|
ALZHEIMER DISEASE 10
|
0.020 |
Biomarker
|
disease |
BEFREE |
A human macrophage-colony-stimulating-factor (M-CSF) gene inserted into an expression vector (pRc/CMV-MCSF) was transfected into multidrug-resistant (MDR) human ovarian cancer cells (AD10) to induce secretion of human M-CSF into the medium.
|
8100809 |
1993 |
|
Alzheimer's Disease
|
0.030 |
Biomarker
|
disease |
LHGDN |
We assessed if genetic variability of CSF1 may influence the risk for AD.
|
17192722 |
2006 |
|
Alzheimer's Disease
|
0.030 |
Biomarker
|
disease |
BEFREE |
We assessed if genetic variability of CSF1 may influence the risk for AD.
|
17192722 |
2006 |
|
Alzheimer's Disease
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Using human brain samples [inferior temporal gyrus (ITG) and middle temporal gyrus (MTG)] from distinct cohorts of AD, control and high pathology, or mild cognitive impairment cases, we showed that there was increased expression of CSF-1R and CSF-1 mRNAs in both series of AD cases, and reduced expression of IL-34 mRNA in AD ITG samples.
|
28848420 |
2017 |
|
Alzheimer's Disease
|
0.030 |
Biomarker
|
disease |
BEFREE |
We discovered that systemic administration of human recombinant CSF1 ameliorates memory deficits in a transgenic mouse model of Alzheimer's disease.
|
23296467 |
2013 |
|
Ankylosing spondylitis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Serum levels of matrix metalloproteinase 3 and macrophage colony-stimulating factor 1 correlate with disease activity in ankylosing spondylitis.
|
15478146 |
2004 |
|
Anoxia
|
0.010 |
Biomarker
|
phenotype |
LHGDN |
Elevation of serum macrophage colony-stimulating factor before the clinical manifestations of preeclampsia.
|
14634568 |
2003 |
|
Anti-Basement Membrane Glomerulonephritis
|
0.200 |
Therapeutic
|
disease |
RGD |
Preventive and therapeutic effects of imatinib in Wistar-Kyoto rats with anti-glomerular basement membrane glomerulonephritis.
|
19242505 |
2009 |